Tofacitinib in active ulcerative colitis: Analysis of efficacy based on patient-reported outcomes

被引：1
|
作者：
Panes, J. [1 ]
Su, C. [2 ]
Bushmakin, A. G. [3 ]
Cappelleri, J. C. [3 ]
Mamolo, C. [3 ]
Healey, P. [3 ]
机构：
[1] Hosp Clin Barcelona, Gastroenterol, Barcelona, Spain
[2] Pfizer Inc, Collegeville, PA USA
[3] Pfizer Inc, Groton, CT 06340 USA
来源：
JOURNAL OF CROHNS & COLITIS | 2014年 / 8卷
关键词：
D O I：
10.1016/S1873-9946(14)60100-8
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
DOP075
引用
收藏
页码：S51 / S51
页数：1
相关论文
共 50 条
  • [1] Randomized trial of tofacitinib in active ulcerative colitis: analysis of efficacy based on patient-reported outcomes
    Panes, Julian
    Su, Chinyu
    Bushmakin, Andrew G.
    Cappelleri, Joseph C.
    Mamolo, Carla
    Healey, Paul
    [J]. BMC GASTROENTEROLOGY, 2015, 15
  • [2] Randomized trial of tofacitinib in active ulcerative colitis: analysis of efficacy based on patient-reported outcomes
    Julián Panés
    Chinyu Su
    Andrew G Bushmakin
    Joseph C Cappelleri
    Carla Mamolo
    Paul Healey
    [J]. BMC Gastroenterology, 15
  • [3] Improvement in patient-reported outcomes in 2 Phase 3 studies of tofacitinib in patients with moderately to severely active ulcerative colitis
    Panes, J.
    Su, C.
    Marren, A.
    Yu, D.
    Woodworth, D.
    Zhang, H.
    Healey, P.
    [J]. JOURNAL OF CROHNS & COLITIS, 2016, 10 : S283 - S284
  • [4] Improvement in Patient-Reported Outcomes in Two Phase 3 Induction Studies of Tofacitinib in Patients With Moderately to Severely Active Ulcerative Colitis
    Panes, Julian
    Su, Chinyu
    Marren, Amy
    Yu, Dahong
    Woodworth, Deborah A.
    Zhang, Haiying
    Healey, Paul J.
    [J]. GASTROENTEROLOGY, 2016, 150 (04) : S1003 - S1003
  • [5] Patient-Reported Outcome Improvement with Tofacitinib in the Ulcerative Colitis OCTAVE Clinical Program
    Hudesman, David
    Torres, Joana
    Salese, Leonardo
    Woolcott, John C.
    Mundayat, Rajiv
    Su, Chinyu
    Mosli, Mahmoud H.
    Allegretti, Jessica R.
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 : S403 - S404
  • [6] PATIENT-REPORTED OUTCOMES ON THE IMPACT OF ORAL STEROID TREATMENT IN ULCERATIVE COLITIS
    Jayasooriya, Nishani
    Blackwell, Jonathan
    Pollok, Richard
    [J]. GUT, 2021, 70 : A78 - A79
  • [7] Clinical Long-Term Outcomes of Patient-Reported Outcomes in the Prospective Real-World Tofacitinib Response in Ulcerative Colitis Registry
    Herfarth, Hans H.
    Afzali, Anita
    Fischer, Monika
    Hudesman, David
    Abdalla, Maisa
    Mccabe, Robert
    Cohen, Benjamin L.
    Ungaro, Ryan C.
    Harlan, Will
    Hanson, John
    Konijeti, Gauree G.
    Polyak, Steven
    Ritter, Timothy
    Salzberg, Bruce
    Seminerio, Jennifer
    English, Emily
    Zhang, Xian
    Long, Millie D.
    [J]. CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY, 2024, 15 (03)
  • [8] PREDICTIVE VALUE OF PATIENT-REPORTED OUTCOMES TO MUCOSAL HEALING IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS
    Colombel, J. F.
    Han, C.
    Reinisch, W.
    Feagan, B.
    Marano, C.
    Strauss, R.
    Johanns, J.
    Zhang, H.
    Gibson, P.
    Collins, J.
    Rutgeerts, P.
    Sandborn, W.
    [J]. VALUE IN HEALTH, 2014, 17 (03) : A40 - A40
  • [9] Comparing Patient-Reported Outcomes Among Anti-TNF Experienced Patients With Ulcerative Colitis Initiating Vedolizumab Versus Tofacitinib
    Kappelman, Michael D.
    Long, Millie D.
    Zhang, Xian
    Lin, Feng-Chang
    Weisbein, Laura
    Chen, Wenli
    Burris, Jessica
    Dorand, Jennifer E.
    Parlett, Lauren E.
    Fehlmann, Tara
    Brensinger, Colleen M.
    Haynes, Kevin
    Nair, Vinit
    Kaul, Alan F.
    Dobes, Angela
    Lewis, James D.
    [J]. CROHNS & COLITIS 360, 2023, 5 (03)
  • [10] Tofacitinib in Active Ulcerative Colitis
    Cottone, Mario
    Orlando, Ambrogio
    Papi, Claudio
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (20): : 1960 - 1960
12345